Antiviral potential of curcumin

Journal of Functional Foods

Volumn 40, Issue , 2018, Pages 692-699

  Mathew, Dony ^a   Hsu, Wei Li ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Antiviral; Curcumin; Molecular mechanisms; NF B; PI3K Akt

Indexed keywords

EID: 85038017358     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2017.12.017     Document Type: Review

References (144)

1. Abe, Y., Hashimoto, S., Horie, T., Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacological Research 39:1 (1999), 41–47, 10.1006/phrs.1998.0404.
2. Aggarwal, B.B., Gupta, S.C., Kim, J.H., Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 119:3 (2012), 651–665, 10.1182/blood-2011-04-325225.
3. Ahmed, J., Tan, Y., Ambegaokar, S., Effects of curcumin on vesicular stomatitis virus (VSV) infection and dicer-1 expression. The FASEB Journal, 31(1), 2017, 622.611.
4. Ali, A., Banerjea, A.C., Curcumin inhibits HIV-1 by promoting Tat protein degradation. Scientific Reports, 6, 2016, 27539, 10.1038/srep27539.
5. Allegri, P., Mastromarino, A., Neri, P., Management of chronic anterior uveitis relapses: Efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clinical Ophthalmology 4 (2010), 1201–1206, 10.2147/OPTH.S13271.
6. Anggakusuma, Colpitts, C.C., Schang, L.M., Rachmawati, H., Frentzen, A., Pfaender, S., Steinmann, E., Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut 63:7 (2014), 1137–1149, 10.1136/gutjnl-2012-304299.
7. Antony, B., Merina, B., Iyer, V.S., Judy, N., Lennertz, K., Joyal, S., A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian Journal of Pharmaceutical Sciences 70:4 (2008), 445–449, 10.4103/0250-474X.44591.
8. Arnott, C.H., Scott, K.A., Moore, R.J., Hewer, A., Phillips, D.H., Parker, P., Owens, D.M., Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway. Oncogene 21:31 (2002), 4728–4738, 10.1038/sj.onc.1205588.
9. Asikainen, S., Heikkinen, L., Wong, G., Storvik, M., Functional characterization of endogenous siRNA target genes in Caenorhabditis elegans. BMC Genomics, 9, 2008, 270.
10. Bayet-Robert, M., Kwiatkowski, F., Leheurteur, M., Gachon, F., Planchat, E., Abrial, C., Chollet, P., Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biology & Therapy 9:1 (2010), 8–14.
11. Bolken, T.C., Hruby, D.E., Discovery and development of antiviral drugs for biodefense: Experience of a small biotechnology company. Antiviral Research 77:1 (2008), 1–5, 10.1016/j.antiviral.2007.07.003.
12. Bowman, T., Garcia, R., Turkson, J., Jove, R., STATs in oncogenesis. Oncogene 19:21 (2000), 2474–2488, 10.1038/sj.onc.1203527.
13. Cao, J., Jia, L., Zhou, H.M., Liu, Y., Zhong, L.F., Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicological Sciences 91:2 (2006), 476–483, 10.1093/toxsci/kfj153.
14. Carr, A., Toxicity of antiretroviral therapy and implications for drug development. Nature Reviews Drug Discovery 2 (2003), 624–634.
15. Catlett-Falcone, R., Landowski, T.H., Oshiro, M.M., Turkson, J., Levitzki, A., Savino, R., Jove, R., Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:1 (1999), 105–115.
16. Chen, T.Y., Chen, D.Y., Wen, H.W., Ou, J.L., Chiou, S.S., Chen, J.M., Hsu, W.L., Inhibition of enveloped viruses infectivity by curcumin. PLoS ONE, 8(5), 2013, e62482, 10.1371/journal.pone.0062482.
17. Chen, D., Dou, Q.P., The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention. Current Protein & Peptide Science 11:6 (2010), 459–470.
18. Chen, M.H., Lee, M.Y., Chuang, J.J., Li, Y.Z., Ning, S.T., Chen, J.C., Liu, Y.W., Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. International Journal of Molecular Medicine 30:5 (2012), 1021–1028, 10.3892/ijmm.2012.1096.
19. Chen, D.-Y., Shien, J.-H., Tiley, L., Chiou, S.-S., Wang, S.-Y., Chang, T.-J., Hsu, W.-L., Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chemistry 119:4 (2010), 1346–1351.
20. Chen, D.Y., Shien, J.H., Tiley, L., Chiou, S.S., Wang, S.Y., Chang, T.J., Hsu, W.L., Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chemistry 119:4 (2010), 1346–1351.
21. Cheng, A.L., Hsu, C.H., Lin, J.K., Hsu, M.M., Ho, Y.F., Shen, T.S., Hsieh, C.Y., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research 21:4B (2001), 2895–2900.
22. Çıkrıkçı, Simay, Mozioglu, E., Yılmaz, H., Biological activity of curcuminoids isolated from Curcuma longa. Records of Natural Products 2:1 (2008), 19–24.
23. Cruz-Correa, M., Shoskes, D.A., Sanchez, P., Zhao, R., Hylind, L.M., Wexner, S.D., Giardiello, F.M., Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clinical Gastroenterology and Hepatology 4:8 (2006), 1035–1038, 10.1016/j.cgh.2006.03.020.
24. De, R., Kundu, P., Swarnakar, S., Ramamurthy, T., Chowdhury, A., Nair, G.B., Mukhopadhyay, A.K., Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrobial Agents and Chemotherapy 53:4 (2009), 1592–1597, 10.1128/AAC.01242-08.
25. Devadas, K., Dhawan, S., Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction. Journal of Immunology 176:7 (2006), 4252–4257.
26. Dey, A., Tergaonkar, V., Lane, D.P., Double-edged swords as cancer therapeutics: Simultaneously targeting p53 and NF-kappaB pathways. Nature Reviews Drug Discovery 7 (2008), 1031–1040.
27. Dhillon, N., Aggarwal, B.B., Newman, R.A., Wolff, R.A., Kunnumakkara, A.B., Abbruzzese, J.L., Kurzrock, R., Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research 14:14 (2008), 4491–4499, 10.1158/1078-0432.CCR-08-0024.
28. Diehl, N., Schaal, H., Make yourself at home: Viral hijacking of the PI3K/Akt signaling pathway. Viruses 5:12 (2013), 3192–3212, 10.3390/v5123192.
29. Ding, S.W., RNA-based antiviral immunity. Nature Reviews Immunology 10:9 (2010), 632–644, 10.1038/nri2824.
30. Dolin, R., Reichman, R.C., Madore, H.P., Maynard, R., Linton, P.N., Webber-Jones, J., A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. New England Journal of Medicine 307:10 (1982), 580–584, 10.1056/NEJM198209023071002.
31. Dutta, K., Ghosh, D., Basu, A., Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin-proteasome system. Journal of Neuroimmune Pharmacology 4:3 (2009), 328–337, 10.1007/s11481-009-9158-2.
32. Elena, S.F., Sanjuan, R., Adaptive value of high mutation rates of RNA viruses: Separating causes from consequences. Journal of Virology 79:18 (2005), 11555–11558, 10.1128/JVI.79.18.11555-11558.2005.
33. Fang, J.G., Lu, J., Holmgren, A., Thioredoxin reductase is irreversibly modified by curcumin – A novel molecular mechanism for its anticancer activity. Journal of Biological Chemistry 280:26 (2005), 25284–25290, 10.1074/jbc.M414645200.
34. Favaloro, B., Allocati, N., Graziano, V., Di Ilio, C., De Laurenzi, V., Role of apoptosis in disease. Aging (Albany NY) 4:5 (2012), 330–349, 10.18632/aging.100459.
35. Ferreira, V.H., Nazli, A., Dizzell, S.E., Mueller, K., Kaushic, C., The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2. PLoS ONE, 10(4), 2015, e0124903, 10.1371/journal.pone.0124903.
36. Fontana, R.J., Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology 49:5 Suppl (2009), S185–S195, 10.1002/hep.22885.
37. Gamero, A.M., Young, H.A., Wiltrout, R.H., Inactivation of Stat3 in tumor cells: Releasing a brake on immune responses against cancer?. Cancer Cell 5 (2004), 111–112.
38. Gao, Y., Li, Z.G., Sun, M., Li, H.L., Guo, C.Y., Cui, J., Zhai, G.X., Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Development and Industrial Pharmacy 36:10 (2010), 1225–1234, 10.3109/03639041003695139.
39. Ghalaut, V.S., Sangwan, L., Dahiya, K., Ghalaut, P.S., Dhankhar, R., Saharan, R., Effect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia. Journal of Oncology Pharmacy Practice 18 (2012), 186–190.
40. Golombick, T., Diamond, T.H., Badmaev, V., Manoharan, A., Ramakrishna, R., The potential role of curcumin in patients with monoclonal gammopathy of undefined significance-its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker. Clinical Cancer Research 15:18 (2009), 5917–5922, 10.1158/1078-0432.Ccr-08-2217.
41. Gou, M., Men, K., Shi, H., Xiang, M., Zhang, J., Song, J., Qian, Z., Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 3:4 (2011), 1558–1567, 10.1039/c0nr00758g.
42. Gupta, K.K., Bharne, S.S., Rathinasamy, K., Naik, N.R., Panda, D., Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding. FEBS Journal 273:23 (2006), 5320–5332, 10.1111/j.1742-4658.2006.05525.x.
43. Gupta, P., Garg, P., Roy, N., Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors. Molecular Diversity 15:3 (2011), 733–750, 10.1007/s11030-011-9304-7.
44. Gupta, S.C., Patchva, S., Aggarwal, B.B., Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS Journal 15:1 (2013), 195–218, 10.1208/s12248-012-9432-8.
45. Gupta, P., Sharma, A., Garg, P., Roy, N., QSAR study of curcumine derivatives as HIV-1 integrase inhibitors. Current Computer-Aided Drug Design 9:1 (2013), 141–150.
46. Gupta, S.C., Sundaram, C., Reuter, S., Aggarwal, B.B., Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy. Biochimica et Biophysica Acta 10–12 (2010), 775–787.
47. Hashiba, T., Suzuki, M., Nagashima, Y., Suzuki, S., Inoue, S., Tsuburai, T., Ishigatubo, Y., Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice. Gene Therapy 8:19 (2001), 1499–1507, 10.1038/sj.gt.3301540.
48. He, Z.Y., Shi, C.B., Wen, H., Li, F.L., Wang, B.L., Wang, J., Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Investigation 29:3 (2011), 208–213, 10.3109/07357907.2010.550592.
49. Hergenhahn, M., Soto, U., Weninger, A., Polack, A., Hsu, C.H., Cheng, A.L., Rosl, F., The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells. Molecular Carcinogenesis 33:3 (2002), 137–145.
50. Hill-Batorski, L., Halfmann, P., Neumann, G., Kawaoka, Y., The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication. Journal of Virology 87:24 (2013), 13795–13802, 10.1128/JVI.02422-13.
51. Hima Bindu, A., Naga Anusha, P., Adverse effects of highly active anti-retroviral therapy (HAART). Journal of Antivirals and Antiretrovirals 3 (2011), 060–064.
52. Hung, W.C., Chen, F.Y., Lee, C.C., Sun, Y., Lee, M.T., Huang, H.W., Membrane-thinning effect of curcumin. Biophysical Journal 94:11 (2008), 4331–4338, 10.1529/biophysj.107.126888.
53. Ide, H., Tokiwa, S., Sakamaki, K., Nishio, K., Isotani, S., Muto, S., Horie, S., Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate 70 (2010), 1127–1133.
54. Ingolfsson, H.I., Thakur, P., Herold, K.F., Hobart, E.A., Ramsey, N.B., Periole, X., Andersen, O.S., Phytochemicals perturb membranes and promiscuously alter protein function. ACS Chemical Biology 9:8 (2014), 1788–1798, 10.1021/cb500086e.
55. Javvadi, P., Segan, A.T., Tuttle, S.W., Koumenis, C., The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Molecular Pharmacology 73:5 (2008), 1491–1501, 10.1124/mol.107.043554.
56. Jeong, E.H., Vaidya, B., Cho, S.Y., Park, M.A., Kaewintajuk, K., Kim, S.R., Kim, D., Identification of regulators of the early stage of viral hemorrhagic septicemia virus infection during curcumin treatment. Fish & Shellfish Immunology 45:1 (2015), 184–193, 10.1016/j.fsi.2015.03.042.
57. Joe, B., Vijaykumar, M., Lokesh, B.R., Biological properties of curcumin-cellular and molecular mechanisms of action. Critical Reviews in Food Science and Nutrition 44:2 (2004), 97–111, 10.1080/10408690490424702.
58. Kanai, M., Yoshimura, K., Asada, M., Imaizumi, A., Suzuki, C., Matsumoto, S., Aggarwal, B.B., A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemotheraphy and Pharmacology 68:1 (2011), 157–164, 10.1007/s00280-010-1470-2.
59. Kasdagly, M., Radhakrishnan, S., Reddivari, L., Veeramachaneni, D.N.R., Vanamala, J., Colon carcinogenesis: Influence of Western diet-induced obesity and targeting stem cells using dietary bioactive compounds. Nutrition 30:11–12 (2014), 1242–1256, 10.1016/j.nut.2014.02.016.
60. Kim, K., Kim, K.H., Kim, H.Y., Cho, H.K., Sakamoto, N., Cheong, J., Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Letters 584:4 (2010), 707–712, 10.1016/j.febslet.2009.12.019.
61. Kim, S.G., Veena, M.S., Basak, S.K., Han, E., Tajima, T., Gjertson, D.W., Wang, M.B., Curcumin treatment suppresses IKKbeta kinase activity of salivary cells of patients with head and neck cancer: A pilot study. Clinical Cancer Research 17:18 (2011), 5953–5961, 10.1158/1078-0432.CCR-11-1272.
62. Kumar, A., Dhamgaye, S., Maurya, I.K., Singh, A., Sharma, M., Prasad, R., Curcumin targets cell wall integrity via calcineurin-mediated signaling in Candida albicans. Antimicrobial Agents and Chemotherapy 58:1 (2014), 167–175, 10.1128/AAC.01385-13.
63. Kurita, T., Makino, Y., Novel curcumin oral delivery systems. Anticancer Research 33:7 (2013), 2807–2821.
64. Lal, B., Kapoor, A.K., Asthana, O.P., Agrawal, P.K., Prasad, R., Kumar, P., Srimal, R.C., Efficacy of curcumin in the management of chronic anterior uveitis. Phytotherapy Research 13:4 (1999), 318–322, 10.1002/(SICI)1099-1573(199906)13:4318::AID-PTR4453.0.CO;2-7.
65. Lampe, V., Miłobędzka, J., Studien über Curcumin. Berichte der Deutschen Chemischen Gesellschaft 46 (1913), 2235–2240.
66. Lao, C.D., Ruffin, M.T.t., Normolle, D., Heath, D.D., Murray, S.I., Bailey, J.M., Brenner, D.E., Dose escalation of a curcuminoid formulation. BMC Complementary and Alternative Medicine, 6, 2006, 10, 10.1186/1472-6882-6-10.
67. Lawhavinit, O., Kongkathip, N., Kongkathip, B., & Kasetsart, J. (2010). Antimicrobial activity of curcuminoids from Curcuma longa L. on pathogenic bacteria of shrimp and chicken. Kasetsart Journal—Natural Science, 44, 364–371.
68. Lee, P.J., Alam, J., Wiegand, G.W., Choi, A.M., Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proceedings of the National Academy of Sciences of the United States of America 93:19 (1996), 10393–10398.
69. Lee, W.H., Loo, C.Y., Bebawy, M., Luk, F., Mason, R.S., Rohanizadeh, R., Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21st century. Current Neuropharmacology 11:4 (2013), 338–378, 10.2174/1570159X11311040002.
70. Lehmann, E., El-Tantawy, W.H., Ocker, M., Bartenschlager, R., Lohmann, V., Hashemolhosseini, S., Sass, G., The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Hepatology 51:2 (2010), 398–404, 10.1002/hep.23339.
71. Leu, T.H., Su, S.L., Chuang, Y.C., Maa, M.C., Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity. Biochemical Pharmacology 66:12 (2003), 2323–2331.
72. Li, X., Chen, S., Zhang, B., Li, M., Diao, K., Zhang, Z., Chen, H., In situ injectable nano-composite hydrogel composed of curcumin, N,O-carboxymethyl chitosan and oxidized alginate for wound healing application. International Journal of Pharmaceutics 437:1–2 (2012), 110–119, 10.1016/j.ijpharm.2012.08.001.
73. Ludwig, S., Planz, O., Influenza viruses and the NF-kappaB signaling pathway – towards a novel concept of antiviral therapy. Biological Chemistry 389:10 (2008), 1307–1312, 10.1515/BC.2008.148.
74. Lv, Y., An, Z., Chen, H., Wang, Z., Liu, L., Mechanism of curcumin resistance to human cytomegalovirus in HELF cells. BMC Complementary and Alternative Medicine, 14, 2014, 284, 10.1186/1472-6882-14-284.
75. Lv, Y., Gong, L., Wang, Z., Han, F., Liu, H., Lu, X., Liu, L., Curcumin inhibits human cytomegalovirus by downregulating heat shock protein 90. Molecular Medicine Reports 12:3 (2015), 4789–4793, 10.3892/mmr.2015.3983.
76. Lv, Y., Lei, N., Wang, D., An, Z., Li, G., Han, F., Liu, L., Protective effect of curcumin against cytomegalovirus infection in Balb/c mice. Environmental Toxicology and Pharmacology 37:3 (2014), 1140–1147, 10.1016/j.etap.2014.04.017.
77. Maines, M.D., Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB Journal 2:10 (1988), 2557–2568.
78. Martins, C.V.B., da Silva, D.L., Neres, A.T.M., Magalhaes, T.F.F., Watanabe, G.A., Modolo, L.V., de Resende, M.A., Curcumin as a promising antifungal of clinical interest. Journal of Antimicrobial Chemotherapy 63:2 (2009), 337–339, 10.1093/jac/dkn488.
79. McFarlin, B.K., Venable, A.S., Henning, A.L., Sampson, J.N., Pennel, K., Vingren, J.L., Hill, D.W., Reduced inflammatory and muscle damage biomarkers following oral supplementation with bioavailable curcumin. BBA Clinical 5 (2016), 72–78, 10.1016/j.bbacli.2016.02.003.
80. McNally, S.J., Harrison, E.M., Ross, J.A., Garden, O.J., Wigmore, S.J., Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. International Journal of Molecular Medicine 19:1 (2007), 165–172.
81. Misra, R., Sahoo, S.K., Coformulation of doxorubicin and curcumin in poly(D, L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells. Molecular Pharmaceutics 8:3 (2011), 852–866, 10.1021/mp100455h.
82. Moghadamtousi, S.Z., Kadir, H.A., Hassandarvish, P., Tajik, H., Abubakar, S., Zandi, K., A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Research International, 2014, 2014, 186864, 10.1155/2014/186864.
83. Morishima, T., Togashi, T., Yokota, S., Okuno, Y., Miyazaki, C., Tashiro, M., & Okabe, N. J. (2002). Collaborative Study Group on Influenza-Associated Encephalopathy in Japan. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clinical Infectious Diseases, 35, 512–517.
84. Motterlini, R., Foresti, R., Bassi, R., Green, C.J., Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radical Biology and Medicine 28:8 (2000), 1303–1312.
85. Mounce, B.C., Cesaro, T., Carrau, L., Vallet, T., Vignuzzi, M., Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antiviral Research 142 (2017), 148–157, 10.1016/j.antiviral.2017.03.014.
86. Mukhopadhyay, A., Banerjee, S., Stafford, L.J., Xia, C., Liu, M., Aggarwal, B.B., Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21:57 (2002), 8852–8861, 10.1038/sj.onc.1206048.
87. Naar, A.M., Lemon, B.D., Tjian, R., Transcriptional coactivator complexes. Annual Review of Biochemistry 70 (2001), 475–501, 10.1146/annurev.biochem.70.1.475.
88. Narayan, V., Ravindra, K.C., Chiaro, C., Cary, D., Aggarwal, B.B., Henderson, A.J., Prabhu, K.S., Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication. Journal of Molecular Biology 410:5 (2011), 972–983, 10.1016/j.jmb.2011.04.013.
89. Narayanan, A., Kehn-Hall, K., Senina, S., Lundberg, L., Van Duyne, R., Guendel, I., Kashanchi, F., Curcumin inhibits Rift Valley fever virus replication in human cells. Journal of Biological Chemistry 287:40 (2012), 33198–33214, 10.1074/jbc.M112.356535.
90. Niamsa, N., Sittiwet, C., Antimicrobial activity of curcuma longa aqueous extract. Journal of Pharmacology and Toxicology 4:4 (2009), 173–177.
91. Obata, K., Kojima, T., Masaki, T., Okabayashi, T., Yokota, S., Hirakawa, S., Sawada, N., Curcumin prevents replication of respiratory syncytial virus and the epithelial responses to it in human nasal epithelial cells. PLoS ONE, 8(9), 2013, e70225, 10.1371/journal.pone.0070225.
92. Onoue, S., Takahashi, H., Kawabata, Y., Seto, Y., Hatanaka, J., Timmermann, B., Yamada, S., Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. Journal of Pharmaceutical Sciences 99:4 (2010), 1871–1881, 10.1002/jps.21964.
93. Ou, J.L., Mizushina, Y., Wang, S.Y., Chuang, D.Y., Nadar, M., Hsu, W.L., Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity. FEBS Journal 280:22 (2013), 5829–5840, 10.1111/febs.12503.
94. Padilla, S.L., Rodriguez, A., Gonzales, M.M., Gallego, G.J., Castano, O.J., Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro. Archives of Virology 159:3 (2014), 573–579, 10.1007/s00705-013-1849-6.
95. Pae, H.O., Chung, H.T., Hemeoxygenase-1: Its therapeutic roles in inflammatory diseases. Immune Network 9 (2009), 12–19, 10.4110/in.2009.9.1.12.
96. Pandey, M.K., Kumar, S., Thimmulappa, R.K., Parmar, V.S., Biswal, S., Watterson, A.C., Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells. European Journal of Pharmaceutical Sciences 43:1–2 (2011), 16–24, 10.1016/j.ejps.2011.03.003.
97. Paulraj, F., Abas, F., Lajis, N.H., Othman, I., Hassan, S.S., et al. The curcumin analogue 1,5-bis (2-hydroxyphenyl) 21,4-pentadiene-3-one induces apoptosis and downregulates E6 and E7 oncogene expression in HPV16 and HPV18-infected cervical cancer cells. Molecules 20 (2015), 11830–11860.
98. Peter, B.M., Shirtliff, M.E., Jabra-Rizk, M.A., Antimicrobial peptides: Primeval molecules or future drugs?. PLoS Pathogens, 6, 2010, e1001067.
99. Protzer, U., Seyfried, S., Quasdorff, M., Sass, G., Svorcova, M., Webb, D., Tiegs, G., Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 133:4 (2007), 1156–1165, 10.1053/j.gastro.2007.07.021.
100. Qin, Y., Lin, L., Chen, Y., Wu, S., Si, X., Wu, H., Zhong, Z., Curcumin inhibits the replication of enterovirus 71 in vitro. Acta Pharmaceutica Sinica B 4:4 (2014), 284–294, 10.1016/j.apsb.2014.06.006.
101. Ravindran, J., Prasad, S., Aggarwal, B.B., Curcumin and cancer cells: How many ways can curry kill tumor cells selectively?. AAPS Journal 11:3 (2009), 495–510, 10.1208/s12248-009-9128-x.
102. Rechtman, M.M., Har-Noy, O., Bar-Yishay, I., Fishman, S., Adamovich, Y., Shaul, Y., Shlomai, A., Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha. FEBS Letters 584:11 (2010), 2485–2490, 10.1016/j.febslet.2010.04.067.
103. Reddy, S., & Aggarwal, B. B. (1994). Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Letters, 341, 19–22.
104. Reust, C.E., Common adverse effects of antiretroviral therapy for HIV disease. American Family Physician 83:12 (2011), 1443–1451.
105. Safavy, A., Raisch, K.P., Mantena, S., Sanford, L.L., Sham, S.W., Krishna, N.R., Bonner, J.A., Design and development of water-soluble curcumin conjugates as potential anticancer agents. Journal of Medicinal Chemistry 50:24 (2007), 6284–6288, 10.1021/jm700988f.
106. Satoskar, R.R., Shah, S.J., Shenoy, S.G., Evaluation of antiinflammatory property of curcumin (Diferuloyl Methane) in patients with postoperative inflammation. International Journal of Clinical Pharmacology and Therapeutics 24:12 (1986), 651–654.
107. Seal, A., Aykkal, R., Babu, R.O., Ghosh, M., Docking study of HIV-1 reverse transcriptase with phytochemicals. Bioinformation 5:10 (2011), 430–439.
108. Sen, R., Baltimore, D., Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:5 (1986), 705–716.
109. Sethi, G., Tergaonkar, V., Potential pharmacological control of the NF-kappaB pathway. Trends in Pharmacological Sciences 30:6 (2009), 313–321, 10.1016/j.tips.2009.03.004.
110. Setlur, A.S., Naik, S.Y., Skariyachan, S., Herbal lead as ideal bioactive compounds against probable drug targets of Ebola virus in comparison with known chemical analogue: A computational drug discovery perspective. Interdisciplinary Sciences 9:2 (2017), 254–277, 10.1007/s12539-016-0149-8.
111. Sharma, R.A., Euden, S.A., Platton, S.L., Cooke, D.N., Shafayat, A., Hewitt, H.R., Steward, W.P., Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clinical Cancer Research 10:20 (2004), 6847–6854, 10.1158/1078-0432.CCR-04-0744.
112. Shlomai, A., Paran, N., & Shaul, Y. (2006). PGC-1α controls hepatitis B virus through nutritional signals. PNAS, 103(43), 16003–16008.
113. Si, X., Wang, Y., Wong, J., Zhang, J., McManus, B.M., Luo, H., Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. Journal of Virology 81:7 (2007), 3142–3150, 10.1128/jvi.02028-06.
114. Singh, M., Singh, N., Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Molecular and Cellular Biochemistry 325:1–2 (2009), 107–119, 10.1007/s11010-009-0025-5.
115. Skrzypczak-Jankun, E., Zhou, K., McCabe, N.P., Selman, S.H., Jankun, J., Structure of curcumin in complex with lipoxygenase and its significance in cancer. International Journal of Molecular Medicine 12:1 (2003), 17–24.
116. Sordillo, P.P., Helson, L., Curcumin suppression of cytokine release and cytokine storm. A potential therapy for patients with Ebola and other severe viral infections. In Vivo 29:1 (2015), 1–4.
117. Sreekanth, C.N., Bava, S.V., Sreekumar, E., Anto, R.J., Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Oncogene 30:28 (2011), 3139–3152, 10.1038/onc.2011.23.
118. Starok, M., Preira, P., Vayssade, M., Haupt, K., Salome, L., Rossi, C., EGFR inhibition by curcumin in cancer cells: A dual mode of action. Biomacromolecules 16:5 (2015), 1634–1642, 10.1021/acs.biomac.5b00229.
119. Sui, Z., Salto, R., Li, J., Craik, C., Ortiz de Montellano, P.R., Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorganic & Medicinal Chemistry 1:6 (1993), 415–422.
120. Sun, M., Gao, Y., Guo, C.Y., Cao, F.L., Song, Z.M., Xi, Y.W., Zhai, G.X., Enhancement of transport of curcumin to brain in mice by poly(n-butylcyanoacrylate) nanoparticle. Journal of Nanoparticle Research 12:8 (2010), 3111–3122, 10.1007/s11051-010-9907-4.
121. Syng-Ai, C., Kumari, A.L., Khar, A., Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2. Molecular Cancer Therapeutics 3:9 (2004), 1101–1108.
122. Takeuchi, T., Ishidoh, T., Iijima, H., Kuriyama, I., Shimazaki, N., Koiwai, O., Mizushina, Y., Structural relationship of curcumin derivatives binding to the BRCT domain of human DNA polymerase lambda. Genes to Cells 11:3 (2006), 223–235, 10.1111/j.1365-2443.2006.00937.x.
123. Taub, R., Hepatoprotection via the IL-6/Stat3 pathway. Journal of Clinical Investigation 112:7 (2003), 978–980, 10.1172/JCI19974.
124. Tenhunen, R., Marver, H.S., Schmid, R., The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proceedings of the National Academy of Sciences of the United States of America 61:2 (1968), 748–755.
125. Thangapazham, R.L., Puri, A., Tele, S., Blumenthal, R., Maheshwari, R.K., Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. International Journal of Oncology 32:5 (2008), 1119–1123.
126. Ting, C.Y., Wang, H.E., Yu, C.C., Liu, H.C., Liu, Y.C., Chiang, I.T., Curcumin triggers DNA damage and inhibits expression of DNA repair proteins in human lung cancer cells. Anticancer Research 35:7 (2015), 3867–3873.
127. Treanor, J.J., Hayden, F.G., Vrooman, P.S., Barbarash, R., Bettis, R., Riff, D., Mills, R.G., Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 283:8 (2000), 1016–1024.
128. Tung, W.H., Hsieh, H.L., Lee, I.T., Yang, C.M., Enterovirus 71 induces integrin beta1/EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: Role of HO-1/CO in viral replication. Journal of Cellular Physiology 226:12 (2011), 3316–3329, 10.1002/jcp.22677.
129. Tyagi, P., Singh, M., Kumari, H., Kumari, A., Mukhopadhyay, K., Bactericidal activity of curcumin I is associated with damaging of bacterial membrane. PLoS ONE, 10(3), 2015, 10.1371/journal.pone.0121313.
130. Umar, S., Shah, M.A., Munir, M.T., Yaqoob, M., Fiaz, M., Anjum, S., Umar, W., Synergistic effects of thymoquinone and curcumin on immune response and anti-viral activity against avian influenza virus (H9N2) in turkeys. Poultry Science 95:7 (2016), 1513–1520, 10.3382/ps/pew069.
131. Ungphaiboon, S., Supavita, T., Singchangchai, P., Sungkarak, S., Rattanasuwan, P., & Itharat, A. (2005). Study on antioxidant and antimicrobial activities of turmeric clear liquid soap for wound treatment of HIV patients. Songklanakarin Journal of Science and Technology, 27(2), 269–578.
132. Vadhan-Raj, S., Weber, D.M., Wang, M., Giralt, S.A., Thomas, S.K., Alexanian, R., Aggarwal, B.B., Curcumin downregulates NF-kB and related genes in patients with multiple myeloma: Results of a phase I/II study. Blood, 110(11), 2007 357a-357a.
133. Vajragupta, O., Boonchoong, P., Morris, G.M., Olson, A.J., Active site binding modes of curcumin in HIV-1 protease and integrase. Bioorganic & Medicinal Chemistry Letters 15:14 (2005), 3364–3368, 10.1016/j.bmcl.2005.05.032.
134. Vogel, A., Pelletier, J., Examen chimique de la racine de Curcuma. Journal de Pharmacie 1 (1815), 289–300.
135. Winquist, A.G., Fukuda, K., Bridges, C.B., Cox, N.J., Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR Recommendations and Reports 48:RR-14 (1999), 1–9.
136. Wu, S.Y., Lee, Y.R., Huang, C.C., Li, Y.Z., Chang, Y.S., Yang, C.Y., Liu, Y.W., Curcumin-induced heme oxygenase-1 expression plays a negative role for its anti-cancer effect in bladder cancers. Food and Chemical Toxicology 50:10 (2012), 3530–3536, 10.1016/j.fct.2012.06.045.
137. Xu, F., Mu, X.L., Zhao, J., Effects of curcumin on invasion and metastasis in the human cervical cancer cells Caski. Chinese Journal of Cancer Research 21:2 (2009), 159–162, 10.1007/s11670-009-0159-8.
138. Yadav, R., Jee, B., Awasthi, S.K., Curcumin suppresses the production of pro-inflammatory cytokine interleukin-18 in lipopolysaccharide stimulated murine macrophage-like cells. Indian Journal of Clinical Biochemistry 30:1 (2015), 109–112, 10.1007/s12291-014-0452-2.
139. Yang, X., Jiang, H., Shi, Y., Upregulation of heme oxygenase-1 expression by curcumin conferring protection from hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblasts. Cell and Bioscience, 7, 2017, 20, 10.1186/s13578-017-0146-6.
140. Yang, M., Lee, G., Si, J., Lee, S.J., You, H.J., Ko, G., Curcumin shows antiviral properties against norovirus. Molecules, 21(10), 2016, 10.3390/molecules21101401.
141. Yang, X. X., Li, C. M., & Huang, C. Z. (2016). Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. Nanoscale, 8(5), 3040–3048. http://doi.org/10.1039/c5nr07918g.
142. Zhou, H., Beevers, C.S., Huang, S., Targets of curcumin. Current Drug Targets 12:3 (2011), 332–347.
143. Zhou, Y., Xie, M., Song, Y., Wang, W., Zhao, H., Tian, Y., She, G., Two traditional Chinese medicines Curcumae radix and Curcumae Rhizoma: An ethnopharmacology, phytochemistry, and pharmacology review. Evidence-Based Complementary and Alternative Medicine, 2016(4973128), 2016, 10.1155/2016/4973128.
144. Zhu, L., Ding, X., Zhang, D., Yuan, C., Wang, J., Ndegwa, E., Zhu, G., Curcumin inhibits bovine herpesvirus type 1 entry into MDBK cells. Acta Virologica 59:3 (2015), 221–227.